Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
563,000
-
Total 13F shares
-
136,756
-
Share change
-
-165,197
-
Total reported value
-
$55,744
-
Price per share
-
$0.41
-
Number of holders
-
10
-
Value change
-
-$59,519
-
Number of buys
-
4
-
Number of sells
-
10
Institutional Holders of Bluejay Diagnostics, Inc. - Common Stock (BJDX) as of Q1 2023
As of 31 Mar 2023,
Bluejay Diagnostics, Inc. - Common Stock (BJDX) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
136,756 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, JANE STREET GROUP, LLC, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, Tower Research Capital LLC (TRC), Virtu Financial LLC, ADVISOR GROUP HOLDINGS, INC., and WELLS FARGO & COMPANY/MN.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.